Kenan Sabuncu

Kenan Sabuncu

Auto-generated profile, based on publicly available information

Kenan Sabuncu

University of Health Sciences, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2023 in African Journal of Urology
Verified
Journal Article
Open access
PDF file
OCOsman Can
Osman Can
KSKenan Sabuncu
Kenan Sabuncu
MEMustafa Erkoç
Mustafa Erkoç
MBMuammer Bozkurt
Muammer Bozkurt
EDEyyüp Danış
Eyyüp Danış
AÖAlper Ötünçtemur
Alper Ötünçtemur
Objective: We aimed to determine factors responsible for chronic kidney disease (CKD) following nephrectomy for renal tumours. Methods: A retrospective study was undertaken in patients underwent partial or radical nephrectomy due to kidney tumour between January 2015 and June 2020. Patients with eGFR above 60 ml/min/1.73m2 were included in the study. Demographic information, surgical features, eGFR values and some comorbidities of patients were recorded. The patients were evaluated for the development of CKD according to the CKD-EPI equation postoperatively. Results: One hundred and sixty-six patients who underwent radical (n = 125) or partial (n = 41) nephrectomy were included to study. According to the logistic regression analysis, radical nephrectomy (adjusted OR 0.139 (95% CI 0.038–0.507), p = 0.003), age (adjusted OR 1.037 (95% CI 1.001–1.074), p = 0.045), preoperative proteinuria (adjusted OR 0.251 (95% CI 0.084–0.750) p = 0.013) and preoperative lower eGFR (adjusted OR 0.943 (95% CI 0.917–0.969) p < 0.001) were determined as independent predictor for development of CKD. Conclusions: CKD is an important disease that causes morbidity and mortality. Age, type of surgery and preoperative eGFR and preoperative proteinuria are an independent risk factor for CKD development. Patients should be informed about this problem before surgery.

11 July 2021 in Andrologia
Verified
Journal Article
Open access
PDF file
KSKenan Sabuncu
Kenan Sabuncu
MCMehmet Gokhan Culha
Mehmet Gokhan Culha
Click on the article title to read more.

23 April 2025 in Urologia Journal
Verified
Journal Article
Closed access
RDRecep Burak Degirmentepe
Recep Burak Degirmentepe
MCMehmet Gokhan Culha
Mehmet Gokhan Culha
MKMusab Umeyir Karakanli
Musab Umeyir Karakanli
KSKenan Sabuncu
Kenan Sabuncu
EPEmre Can Polat
Emre Can Polat
AOAlper Otunctemur
Alper Otunctemur
Background: Onabotulinum toxin A injection is recommended for overactive bladder (OAB) resistant to medical treatments. However, success is not universal, and factors influencing outcomes remain unclear. This study evaluates the factors affecting the success of onabotulinum toxin A injection in refractory idiopathic OAB. Methods: Data from patients with resistant idiopathic OAB treated with 100 IU onabotulinum toxin A (BOTOX ® , Allergan, Dublin, Ireland) between January 2019 and August 2023 were analyzed. Demographic data and symptom duration were recorded. Patients were evaluated pre- and post-procedure using the overactive bladder symptom score (OABSS) and 3-day bladder diaries. A ⩾50% improvement in OABSS was considered treatment success. Botox was injected at 20 sites (5 IU per site) via 22 Fr rigid cystoscope under sedoanalgesia. Results: A total of 210 patients (80.5% female, n = 169) with a mean age of 53.76 ± 14.90 years were included. Symptom duration averaged 39.82 ± 22.28 months. Wet OAB was diagnosed in 83.3% ( n = 175), while 16.7% ( n = 35) had dry OAB. Pre-procedure mean OABSS was 9.18 ± 1.31, daily micturition 8.67 ± 1.52, urge incontinence 2.57 ± 1.28, nocturia 1.87 ± 0.75, and pad use 2.44 ± 1.24/day. Treatment success was achieved in 82.4% ( n = 173). Conclusion: The degree of patient complaints, particularly daily micturition frequency, significantly affects treatment success. Patients with higher daily micturition may require advanced interventions beyond Botox.

4 July 2025
Verified
Book
Closed access
PDF file
KSKenan Sabuncu
Kenan Sabuncu
MÇMehmet Gökhan Çulha
Mehmet Gökhan Çulha
GÇGökhan Çevik
Gökhan Çevik
FBFunda Büyükyılmaz
Funda Büyükyılmaz
SÜSeher Ünver
Seher Ünver
EAElif Gezginci Akpınar
Elif Gezginci Akpınar
Ürogenital Sistem Anatomisi Kenan SABUNCU Mehmet Gökhan ÇULHA Üriner Sistem Fizyolojisi Gökhan ÇEVİK Ürolojik Muayene ve Tanı Testlerinde Hemşirenin Rol ve Sorumlulukları Funda BÜYÜKYILMAZ Üst Üriner Sistem Perkütan Girişimleri Seher ÜNVER Ürolojik Laparoskopik Cerrahi Nermin OCAKTAN Ürolojik Robotik Cerrahi Hatice Merve ALPTEKİN Ayfer ÖZBAŞ Ürolojide Lazer Kullanımı Esra EREN Transuretral Rezeksiyon ve Diğer Transuretral Yöntemler Pınar ONGÜN Endoüroloji ve Girişimsel Üroradyolojide Hemşirenin Rolü Banu KATRAN Üriner Sistem Enfeksiyonları ve Hemşirelik Bakımı Rabia GÖRÜCÜ Ezgi SEYHAN AK Üriner Sistem Taş Hastalığı ve Hemşirelik Bakımı Ümmü YILDIZ FINDIK Duygu SOYDAŞ Böbrek Kanseri ve Hemşirelik Bakımı Öykü KARA İkbal ÇAVDAR Üreter Kanseri ve Hemşirelik Bakımı Zeynep TEMİZ Mesane Kanseri ve Hemşirelik Bakımı Askeri ÇANKAYA Meryem YAVUZ van GIERSBERGEN Prostat Kanseri ve Hemşirelik Bakımı Tuğba SINMAZ Ayfer ÖZBAŞ Üretra Kanseri ve Hemşirelik Bakımı Açelya TÜRKMEN Yasemin ÖZHANLI Testis Tümörleri ve Hemşirelik Bakımı Ebru KARAZEYBEK Cafer ÖZDEMİR Penis Kanseri ve Hemşirelik Bakımı Yasemin USLU Üriner Sistem Travmaları ve Hemşirelik Bakımı Ayla YAVUZ KARAMANOĞLU Üriner Kontinans ve Hemşirelik Bakımı Fatma VURAL Nazife Gamze ÖZER ÖZLÜ Üriner Kateterizasyon Uygulamaları Yeliz ÇULHA Kadın Cinsel İşlev Bozukluklarında Hemşirelik Bakımı Çiğdem BİLGE Meltem MECDİ KAYDIRAK Erkek Cinsel İşlev Bozukluklarında Hemşirelik Bakımı Elif GEZGİNCİ AKPINAR

4 July 2025
Verified
Book Chapter
Closed access
KSKenan Sabuncu
Kenan Sabuncu
MÇMehmet Gökhan Çulha
Mehmet Gökhan Çulha
Bu bölüm, ürogenital sistemin anatomisi hakkında kapsamlı bir bilgi sunmak amacıyla yazılmıştır. Ürogenital sistem, boşaltım ve üreme organlarını içeren karmaşık bir yapıdır ve bu organların anatomik ilişkileri, fonksiyonları ve kanlanmaları detaylı bir şekilde ele alınmıştır. Bu organları üriner ve genital sistem olarak değerlendirmek daha anlaşılır olabilir ancak bu yapılar birbiriyle etkileşim halinde olan ve beraber fonksiyon gören yapılardır. Üriner sistem idrar oluşumu ve atılımını sağlayan organları içerir. Böbrekler, üreterler, mesane ve üretra bu sistemin ana bileşenleridir. Bu fonksiyonel yapıyı sırasıyla değerlendirecek olursak böbrekler esas olarak idrar üretiminde görevlidir. Ardından bu idrar üreterler aracılılığıyla mesaneye aktarılır ve sonrasında üretra aracılığıyla miksiyon yoluyla vücuttan atılır. Genital sistemin ana bileşenleri ise erkeklerde testis, epididim, prostat ve üretradır. Testislerde sperm üretiminin ardından spermler epididim yoluyla seminal vezikül ve prostat salgısıyla beraber ejekülasyon yoluyla yine üretradan atılır. Kadın uterusuna ilerleyen bu spermler overlerden salgılanan ovumun döllenmesini –fertilizasyonu sağlar. Metin, ürogenital sistemin karmaşık yapısını ve bu yapının nasıl işlediğini anlamak için gerekli tüm bilgileri sunmaktadır. Ürogenital sistemin anatomisi, üroloji alanında çalışan sağlık profesyonelleri için kritik bir konudur ve bu tür detaylı bilgiler, klinik uygulamalar açısından büyük önem taşımaktadır. This section is written to provide comprehensive information about the anatomy of the urogenital system. The urogenital system is a complex structure that includes excretory and reproductive organs, and the anatomical relationships, functions, and blood supply of these organs are discussed in detail. It may be more understandable to evaluate these organs as the urinary and genital systems, but these structures interact with each other and function together. The urinary system includes organs that provide urine formation and excretion. The kidneys, ureters, bladder, and urethra are the main components of this system. If we evaluate this functional structure in order, the kidneys are primarily responsible for urine production. Then, this urine is transferred to the bladder via the ureters and then excreted from the body via micturition via the urethra. The main components of the genital system in men are the testicles, epididymis, prostate, and urethra. After sperm production in the testicles, sperm are expelled from the urethra again via ejaculation with the seminal vesicle and prostate secretion via the epididymis. These sperm, which move into the female uterus, provide fertilization of the ovum released from the ovaries. The text provides all the information necessary to understand the complex structure of the urogenital system and how it functions. The anatomy of the urogenital system is a critical issue for healthcare professionals working in the field of urology, and such detailed information is of great importance for clinical practice.

1 January 2026 in Acta Cirurgica Brasileira
Verified
Journal Article
Open access
KSKenan Sabuncu
Kenan Sabuncu
MSMehmet Ali Sezgin
Mehmet Ali Sezgin
EPEmre Can Polat
Emre Can Polat
EMErkan Merder
Erkan Merder
AÖAlper Ötünçtemur
Alper Ötünçtemur
LÖLevent Özcan
Levent Özcan
Purpose: To investigate the protective effects of syringic acid (SA) against testicular ischemia–reperfusion (I/R) injury during different reperfusion periods in an experimental rat model. Methods: Forty-eight male Wistar albino rats were randomly assigned to six groups: control, sham, torsion/detorsion (T/D) 4 h, T/D + SA 4 h, T/D 24 h, and T/D + SA 24 h. Testicular torsion was induced by 720° rotation of the left testis for 2 h, followed by detorsion and 4 or 24 h reperfusion. SA (10 mg/kg) was administered intraperitoneally 30 min before detorsion. Oxidative stress markers, histopathological alterations, and immunohistochemical expressions of apoptotic protease activating factor-1 (APAF-1) and inducible nitric oxide synthase were evaluated. Results: T/D significantly decreased total antioxidant status and glutathione levels while increasing myeloperoxidase activity and APAF-1/inducible nitric oxide synthase (iNOS) expressions compared with controls (p < 0.001). SA treatment restored antioxidant capacity and attenuated inflammatory and apoptotic responses (p < 0.05). Histopathological analyses demonstrated lower Cosentino scores and higher Johnsen scores in SA-treated groups than in untreated T/D groups (p < 0.05). Malondialdehyde levels showed no significant intergroup differences. Conclusion: SA attenuates testicular I/R injury by reducing oxidative stress, inflammation, and apoptosis while preserving spermatogenic function and histological integrity.